Proto Labs Inc
For the period ended Jun 30, 2025. Filed Jul 31, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 31, 2025
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2025-03-31; filed 2025-05-02.
0001628280-25-021822
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2025-06-30; filed 2025-07-31.
0001628280-25-037024
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 73 previous paragraphs and 90 current paragraphs.
48 unchanged; 23 reworded; 12 added; 2 removed; 0 previous and 7 current paragraphs rearranged.
Tables are not compared: 6 previous and 8 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (12)
Current report
President and Chief Executive Officer Transition
Current report
On May 21, 2025, the Company announced that the Company’s board of directors appointed Suresh Krishna to serve as the Company’s President and Chief Executive Officer, effective May 20, 2025 (the “Transition Date”), succeeding Robert
Current report
Bodor, who ceased to be the President and Chief Executive Officer and a director of the Company effective as of May 20, 2025. The board also appointed Mr. Krishna to serve as a director of the Company, filling the vacancy left on the Board by Dr. Bodor’s departure, until the earlier of the Company’s 2026 annual meeting of shareholders and until his successor is elected and qualified, or until his earlier death, resignation, or removal.
Current report
General and Administrative. Our general and administrative expenses increased $2.2 million, or 13.0%, during the three months ended June 30, 2025 compared to the same period in 2024 primarily due to increases of $1.8 million in personnel and related costs, primarily related to the previously disclosed CEO transition that occurred during the three months ended June 30, 2025, $0.2 million in administrative costs and $0.2 million in professional services.
Current report
Comparison of Six Months Ended June 30, 2025 and 2024
Current report
Revenue
Current report
Revenue by product line and the related changes for the six months ended June 30, 2025 and 2024 were as follows:
Current report
Cost of Revenue. Cost of revenue increased $6.3 million, or 4.5%, for the six months ended June 30, 2025 compared to the same period in 2024, which was higher than the rate of revenue increase of 3.1% for the six months ended June 30, 2025 compared to the same period in 2024. The increase in cost of revenue of $6.3 million was primarily driven by higher revenue volumes resulting in increases of $4.1 million in raw material and production and fulfillment related costs and $2.7 million in personnel and related costs, primarily due to overtime, medical related costs and incentive compensation, during the six months ended June 30, 2025 compared to the same period in 2024, partially offset by decreases in equipment and facility-related costs of $0.5 million.
Current report
Gross Profit and Gross Margin. Gross profit increased from $114.0 million in the six months ended June 30, 2024 to $115.5 million in the six months ended June 30, 2025. Gross margin decreased from 45.0% in the six months ended June 30, 2024 to 44.2% in the six months ended June 30, 2025.
Current report
Marketing and Sales. Our Marketing and sales expenses increased $2.0 million, or 4.4%, during the six months ended June 30, 2025 compared to the same period in 2024. The increase was driven by increases in personnel and related costs of $1.8 million, primarily due to merit increases and incentive compensation related to commissions, and marketing program cost increases of $0.2 million during the six months ended June 30, 2025 when compared to the same period in 2024.
Current report
Research and Development. Our research and development expenses during the six months ended June 30, 2025 compared to the same period in 2024 were flat primarily due to personnel and related cost increases of $0.4 million, primarily related to incentive compensation, being offset by decreases of $0.2 million in operating costs and $0.2 million in professional services.
Current report
Provision for Income Taxes. Our effective tax rate of 36.6% for the six months ended June 30, 2025 increased 1.6% compared to 35.0% for the same period in 2024. The increase in the effective tax rate is primarily due to an increase in losses in jurisdictions that are not eligible for tax benefits due to valuation allowances. Our income tax provision of $4.6 million for the six months ended June 30, 2025 decreased $0.6 million compared to our income tax provision of $5.3 million for the six months ended June 30, 2024.
Removed paragraphs (2)
Previous report
Cost of Revenue, Gross Profit and Gross Margin
Previous report
Cost of Revenue, Gross Profit and Gross Margin
Reworded paragraphs (23)
Previous wording
Statements contained in this report regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve known and unknown risks, uncertainties and other factors that may cause our results to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in Item 1A. “Risk Factors” of this Form 10-Q, as well as our most recent Annual Report on Form 10-K as filed with the Securities and Exchange Commission (SEC). Other unknown or unpredictable factors also could have material adverse effects on our future results. We cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, we expressly disclaim any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.
Current wording
Statements contained in this report regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve known and unknown risks, uncertainties and other factors that may cause our results to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in Item 1A. “Risk Factors” of this Quarterly Report on Form 10-Q, as well as our most recent Annual Report on Form 10-K as filed with the Securities and Exchange Commission (SEC). Other unknown or unpredictable factors also could have material adverse effects on our future results. We cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, we expressly disclaim any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.
Previous wording
Benefits or costs related to disposal and exit activities. Costs related to disposal and exit activities is driven by our decision to close certain manufacturing facilities in Germany. The expenses consist primarily of operating expenses, including employee severance, write-down of fixed assets and facility-related charges. Benefits may result from adjustments to initial estimates regarding the nature and timing of disposal and exit activities.
Current wording
Costs related to disposal and exit activities. Costs related to disposal and exit activities is driven by our decision to close certain manufacturing facilities in Germany. The expenses consist primarily of operating expenses, including employee severance, write-down of fixed assets and facility-related charges. Benefits may result from adjustments to initial estimates regarding the nature and timing of disposal and exit activities.
Previous wording
Stock-based compensation expense included in the statements of operations data above for the three months ended March 31, 2025 and 2024 were as follows:
Current wording
Stock-based compensation expense included in the statements of operations data above for the three and six months ended June 30, 2025 and 2024 were as follows:
Previous wording
Our revenue decreased $1.7 million, or 1.3%, for the three months ended March 31, 2025 compared to the same period in 2024. The decline in revenue was primarily driven by the leap year in 2024, resulting in a decrease in the number of operating days in the three months ended March 31, 2025 compared to the same period in 2024. By reportable segment, revenue in the United States decreased $1.2 million, or 1.2%, for the three months ended March 31, 2025 compared to the same period in 2024. Revenue in Europe decreased $0.5 million, or 1.8%, for the three months ended March 31, 2025 compared to the same period in 2024. International revenue was negatively impacted by $0.5 million during the three months ended March 31, 2025 compared to the same period in 2024 as a result of foreign currency movements, primarily due to the weakening of the British Pound and Euro relative to the United States Dollar.
Current wording
Our revenue increased $9.4 million, or 7.5%, for the three months ended June 30, 2025 compared to the same period in 2024. The growth in revenue was primarily driven by an increase in average order value for our larger customers in the three months ended June 30, 2025 compared to the same period in 2024. By reportable segment, revenue in the United States increased $12.2 million, or 12.4%, for the three months ended June 30, 2025 compared to the same period in 2024. Revenue in Europe decreased $2.7 million, or 10.1%, for the three months ended June 30, 2025 compared to the same period in 2024. International revenue was favorably impacted by $1.3 million during the three months ended June 30, 2025 compared to the same period in 2024 as a result of foreign currency movements, primarily due to the strengthening of the British Pound and Euro relative to the United States Dollar.
Previous wording
During the three months ended March 31, 2025, we served 21,627 unique customer contacts, which is a decrease of 3.7% from the same period in 2024. Our customer contacts served decreased at a rate higher than our decrease in revenue. This was primarily due to our mix of customers served in the quarter as compared to the same period in 2024 and our strategic focus to earn larger orders from our customers as we strive to be their supplier of choice by serving their custom parts needs through the comprehensive offer of our factory and the Protolabs Network. Our revenue per customer contact grew 2.5% for the three months ended March 31, 2025 compared to the same period in 2024.
Current wording
During the three months ended June 30, 2025, we served 21,775 unique customer contacts, which is adecrease of 3.0% from the same period in 2024. During the three months ended June 30, 2025, our customer contacts served decreased while our revenue grew. This was primarily due to our mix of customers served in the quarter as compared to the same period in 2024 and our strategic focus to earn larger orders from our customers as we strive to be their supplier of choice by serving their custom parts needs through the comprehensive offer of our factory and the Protolabs Network. Our revenue per customer contact grew 10.9% for the three months ended June 30, 2025 compared to the same period in 2024.
Previous wording
By product line, our revenue decrease was driven by a 7.5% decrease in Injection Molding revenue and a 6.4% decrease in 3D Printing revenue, partially offset by a 5.8% increase in CNC Machining revenue, an 18.5% increase in Sheet Metal revenue and a 46.3% increase in Other Revenue, in each case for the three months ended March 31, 2025 compared to the same period in 2024.
Current wording
By product line, our revenue increase was driven by a 20.9% increase in CNC Machining revenue, a 9.7% increase in Sheet Metal revenue and a 69.7% increase in Other Revenue, partially offset by a 3.4% decrease in Injection Molding revenue and a 0.3% decrease in 3D Printing revenue, in each case for the three months ended June 30, 2025 compared to the same period in 2024.
Previous wording
Cost of Revenue. Cost of revenue increased $0.1 million, or 0.1%, for the three months ended March 31, 2025 compared to the same period in 2024, while revenue decreased 1.3% for the three months ended March 31, 2025 compared to the same period in 2024. The increase in the cost of revenue of $0.1 million was primarily driven by increases of $0.4 million in personnel and related costs during the three months ended March 31, 2025 compared to the same period in 2024, partially offset by decreases in equipment and facility-related costs of $0.3 million.
Current wording
Cost of Revenue. Cost of revenue increased $6.2 million, or 9.0%, for the three months ended June 30, 2025 compared to the same period in 2024, while revenue increased 7.5% for the three months ended June 30, 2025 compared to the same period in 2024. The increase in the cost of revenue of $6.2 million was primarily driven by higher revenue volumes resulting in increases of $4.0 million in raw material and production and fulfillment related costs, and $2.4 million in personnel and related costs, primarily due to overtime, medical related costs and incentive compensation, during the three months ended June 30, 2025 compared to the same period in 2024, partially offset by decreases in equipment and facility-related costs of $0.2 million.
Previous wording
Gross Profit and Gross Margin. Gross profit decreased $1.8 million, or 3.1% for the three months ended March 31, 2025 compared to the same period in 2024. Gross margin decreased from 44.9% in the three months ended March 31, 2024 to 44.1% in the three months ended March 31, 2025.
Current wording
Gross Profit and Gross Margin. Gross profit increased $3.2 million, or 5.7%, for the three months ended June 30, 2025 compared to the same period in 2024. Gross margin decreased from 45.0% in the three months ended June 30, 2024 to 44.3% in the three months ended June 30, 2025.
Previous wording
Marketing and Sales. Our marketing and sales expenses increased $0.6 million during the three months ended March 31, 2025 compared to the same period in 2024 primarily due to increases in personnel and related costs of $0.4 million primarily due to merit increases and incentive compensation related to commissions and $0.2 million in marketing program costs.
Current wording
Marketing and Sales. Our marketing and sales expenses increased $1.4 million during the three months ended June 30, 2025 compared to the same period in 2024 primarily due to increases in personnel and related costs of $1.4 million, primarily due to merit increases and incentive compensation related to commissions.
Previous wording
Research and Development. Our research and development expenses decreased $0.6 million, or 5.0%, during the three months ended March 31, 2025 compared to the same period in 2024 primarily due to decreases in personnel and related costs of $0.4 million primarily due largely to lower contract labor spend and $0.4 million in professional services, partially offset by increases of $0.2 million in operating costs.
Current wording
Research and Development. Our research and development expenses increased $0.5 million, or 4.8%, during the three months ended June 30, 2025 compared to the same period in 2024 primarily due to increases in personnel and related costs of $0.8 million, primarily due to incentive compensation and contract labor, partially offset by decreases of $0.2 million in operating costs and $0.1 million in professional services.
Previous wording
Benefits related to exit and disposal. Our decision to exit and close certain operations in Germany resulted in less than $0.1 million in personnel and related cost benefits during the three months ended March 31, 2025. The benefit is the result of timing of employee separation payments and changes from estimated amounts accrued in 2024. We had no costs related to exit and disposal activities during the three months ended March 31, 2024.
Current wording
Costs related to exit and disposal. Our decision to exit and close certain operations in Germany resulted in a $0.2 million expense related to the write-down of fixed assets and $0.1 million in personnel and related cost benefits during the three months ended June 30, 2025. These items are the result of changes from the estimated amounts accrued in 2024 and the timing of employee separation payments. We had no costs related to exit and disposal activities during the three months ended June 30, 2024.
Previous wording
Other income, net. We recognized other income, net of $1.5 million for the three months ended March 31, 2025, an increase of $0.6 million compared to other income, net of $0.9 million for the three months ended March 31, 2024. Other income, net for the three months ended March 31, 2025 primarily consisted of $1.4 million in interest income on investments and other income. Other income, net for the three months ended March 31, 2024 primarily consisted of $1.1 million in interest income on investments and other income, partially offset by $0.2 million of foreign currency losses.
Current wording
Other income, net. We recognized other income, net of $1.7 million for the three months ended June 30, 2025, an increase of $0.3 million compared to other income, net of $1.4 million for the three months ended June 30, 2024. Other income, net for the three months ended June 30, 2025 primarily consisted of $1.1 million in interest income on investments, $0.5 million of foreign currency gains and $0.1 million of other income. Other income, net for the three months ended June 30, 2024 primarily consisted of $1.5 million in interest income on investments and other income, partially offset by $0.1 million of foreign currency losses.
Previous wording
Provision for Income Taxes. Our effective tax rate of 39.9% for the three months ended March 31, 2025 increased 8.1% compared to 31.8% for the same period in 2024. The increase in the effective tax rate was primarily due to a one-time release of tax reserves arising from a successful audit closure in 2024, that did not repeat in 2025. Our income tax provision of $2.4 million for the three months ended March 31, 2025 decreased $0.1 million as compared to our income tax provision of $2.5 million for the same period in 2024.
Current wording
Provision for Income Taxes. Our effective tax rate of 33.7% for the three months ended June 30, 2025 decreased 4.6% compared to 38.3% for the same period in 2024. The decrease in the effective tax rate was primarily due to a decrease in tax expense from the vesting of restricted stock units and the exercise of stock options. Our income tax provision of $2.2 million for the three months ended June 30, 2025 decreased $0.6 million as compared to our income tax provision of $2.8 million for the same period in 2024.
Previous wording
General and Administrative. Our general and administrative expenses increased $0.5 million, or 3.3%, during the three months ended March 31, 2025 compared to the same period in 2024 primarily due to by increases of $1.0 million in administrative costs, partially offset by decreases in personnel and related costs of $0.2 million primarily due to lower headcount and $0.3 million in stock based compensation.
Current wording
General and Administrative. Our general and administrative expenses increased $2.7 million, or 8.2%, during the six months ended June 30, 2025 compared to the same period in 2024 primarily due to increases of $1.5 million in personnel and related costs, primarily related to the previously disclosed CEO transition that occurred during the six months ended June 30, 2025, $1.2 million in administrative costs and $0.2 million in professional services, partially offset by decreases of $0.1 million in stock-based compensation and $0.1 million intangible amortization costs.
Previous wording
The following table summarizes our cash flows during the three months ended March 31, 2025 and 2024:
Current wording
The following table summarizes our cash flows during the six months ended June 30, 2025 and 2024:
Previous wording
Historically, we have primarily financed our operations and capital expenditures through cash flow from operations. We had cash and cash equivalents of $82.7 million as of March 31, 2025, a decrease of $6.4 million from December 31, 2024. The decrease in our cash was primarily due to $1.3 million for purchases of property, equipment and other capital assets, $6.6 million for purchases of marketable securities and $20.9 million in repurchases of common stock, which were partially offset by cash provided by operating activities of $18.4 million and proceeds from call redemptions and maturities of marketable securities of $4.9 million.
Current wording
Historically, we have primarily financed our operations and capital expenditures through cash flow from operations. We had cash and cash equivalents of $90.4 million as of June 30, 2025, an increase of $1.3 million from December 31, 2024. The increase in our cash was primarily due to cash provided by operating activities of $29.0 million and proceeds from call redemptions and maturities of marketable securities of $10.2 million, partially offset by $24.0 million in repurchases of common stock, $11.1 million for purchases of marketable securities and $2.7 million for purchases of property, equipment and other capital assets.
Previous wording
Cash flows from operating activities were $18.4 million during the three months ended March 31, 2025 and primarily consisted of net income of $3.6 million, adjusted for certain non-cash items, including depreciation and amortization of $8.7 million, stock-based compensation expense of $4.0 million, changes in operating assets and liabilities and other items totaling $3.4 million and an impairment of a leased facility of $0.2 million, which were partially offset by deferred taxes of $1.6 million. Cash flows from operating activities were $21.3 million during the three months ended March 31, 2024 and primarily consisted of net income of $5.3 million, adjusted for certain non-cash items, including depreciation and amortization of $9.1 million, stock-based compensation expense of $4.3 million and changes in operating assets and liabilities and other items totaling $4.9 million, which were partially offset by deferred taxes of $2.2 million.
Current wording
Cash flows from operating activities were $29.0 million during the six months ended June 30, 2025 and primarily consisted of net income of $8.0 million, adjusted for certain non-cash items, including depreciation and amortization of $17.3 million, stock-based compensation expense of $8.3 million and an impairments on a leased facility and fixed assets of $0.4 million, which were partially offset by deferred taxes of $4.0 million and changes in operating assets and liabilities and other items totaling $1.0 million. Cash flows from operating activities were $35.8 million during the six months ended June 30, 2024 and primarily consisted of net income of $9.8 million, adjusted for certain non-cash items, including depreciation and amortization of $18.1 million, stock-based compensation expense of $8.5 million and changes in operating assets and liabilities and other items totaling $3.5 million, which were partially offset by deferred taxes of $4.1 million.
Previous wording
Cash flows from operating activities decreased $3.0 million during the three months ended March 31, 2025 compared to the same period in 2024, primarily due to decreases in depreciation and amortization of $0.4 million, decreases in stock-based compensation of $0.3 million, decreases in net income of $1.7 million and changes in operating assets and liabilities totaling $1.5 million, which were partially offset by increases in deferred taxes of $0.7 million, and other property and equipment adjustments of $0.2 million.
Current wording
Cash flows from operating activities decreased $6.8 million during the six months ended June 30, 2025 compared to the same period in 2024, primarily due to changes in operating assets and liabilities and other items totaling $4.5 million, decreases in net income of $1.8 million, decreases in depreciation and amortization of $0.8 million, decreases in stock-based compensation of $0.3 million, which were partially offset by increases in other property and equipment adjustments of $0.4 million and deferred taxes of $0.2 million.
Previous wording
Cash used in investing activities was $2.9 million during the three months ended March 31, 2025, consisting of $1.3 million for net purchases of property, equipment and other capital assets and $1.6 million of purchases of marketable securities, net of proceeds from call redemptions and maturities.
Current wording
Cash used in investing activities was $3.6 million during the six months ended June 30, 2025, consisting of $2.7 million for net purchases of property, equipment and other capital assets and $0.8 million of purchases of marketable securities, net of proceeds from call redemptions and maturities.
Previous wording
Cash provided by investing activities was $4.4 million during the three months ended March 31, 2024, consisting of $7.0 million in proceeds from call redemptions and maturities of marketable securities, which were partially offset by $2.6 million for net purchases of property, equipment and other capital assets.
Current wording
Cash provided by investing activities was $3.7 million during the six months ended June 30, 2024, consisting of $10.4 million in proceeds from call redemptions and maturities of marketable securities, which were partially offset by $6.7 million for net purchases of property, equipment and other capital assets.
Previous wording
Cash used in financing activities was $21.9 million during the three months ended March 31, 2025, consisting of $20.9 million in repurchases of common stock, $1.2 million in purchases of shares withheld for tax obligations associated with equity transactions and $0.1 million for repayments of finance lease obligations, which were partially offset by $0.3 million in proceeds related the exercise of non-qualified stock options.
Current wording
Cash used in financing activities was $25.2 million during the six months ended June 30, 2025, consisting of $24.0 million in repurchases of common stock, $3.1 million in purchases of shares withheld for tax obligations associated with equity transactions and $0.2 million for repayments of finance lease obligations, which were partially offset by $2.1 million in proceeds related to equity plans.
Previous wording
Cash used in financing activities was $16.6 million during the three months ended March 31, 2024, consisting of $16.0 million in repurchases of common stock, $0.5 million in purchases of shares withheld for tax obligations associated with equity transactions and $0.1 million for repayments of finance lease obligations.
Current wording
Cash used in financing activities was $26.9 million during the six months ended June 30, 2024, consisting of $26.9 million in repurchases of common stock, $1.9 million in purchases of shares withheld for tax obligations associated with equity transactions and $0.2 million for repayments of finance lease obligations, which were partially offset by $2.1 million in proceeds from issuance of common stock from equity plans.
Previous wording
We have adopted various accounting policies to prepare the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The preparation of these financial statements requires us to make estimates, judgements and assumptions. Our significant accounting policies and estimates are disclosed in Note 2 to the Consolidated Financial Statements included Part II, Item 8 in our Annual Report on Form 10-K for the year ended December 31, 2024. There were no material changes to our critical accounting policies and estimates during the three months ended March 31, 2025.
Current wording
We have adopted various accounting policies to prepare the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The preparation of these financial statements requires us to make estimates, judgements and assumptions. Our significant accounting policies and estimates are disclosed in Note 2 to the Consolidated Financial Statements included Part II, Item 8 in our Annual Report on Form 10-K for the year ended December 31, 2024. There were no material changes to our critical accounting policies and estimates during the six months ended June 30, 2025.
Rearranged current paragraphs (7)
Current report — wording carried from elsewhere
Revenue by reportable segment and the related changes for the six months ended June 30, 2025 and 2024 were as follows:
Current report — wording carried from elsewhere
Our revenue increased $7.7 million, or 3.1%, for the six months ended June 30, 2025 compared to the same period in 2024. By reportable segment, revenue in the United States increased $11.0 million, or 5.5%, for the six months ended June 30, 2025 compared to the same period in 2024. Revenue in Europe decreased $3.2 million, or 6.0% for the six months ended June 30, 2025 compared to the same period in 2024. International revenue was favorable impacted by $0.9 million during six months ended June 30, 2025 compared to the same period in 2024 as a result of foreign currency movements, primarily the strengthening of the British Pound and Euro relative to the United States Dollar.
Current report — wording carried from elsewhere
During the six months ended June 30, 2025, we served 33,136 unique product developers and engineers, a decrease of 3.5% from the same period in 2024. During the six months ended June 30, 2025, our customer contacts served decreased while our revenue grew. This was primarily due to our mix of customers served during the six months ended June 30, 2025 as compared to the same period in 2024 and our strategic focus to earn larger orders from our customers as we strive to be their supplier of choice by serving their custom parts needs through the comprehensive offer of our factory and the Protolabs Network. Our revenue per customer contact grew 6.8% for the six months ended June 30, 2025 compared to the same period in 2024.
Current report — wording carried from elsewhere
By product line, our revenue increase was driven by a 13.5% increase in CNC Machining revenue, a 13.9% increase in Sheet Metal revenue and a 55.8% increase in Other Revenue, partially offset by a 5.5% decrease in Injection Molding revenue and a 3.4% decrease in 3D Printing revenue in each case for the six months ended June 30, 2025 compared to the same period in 2024.
Current report — wording carried from elsewhere
Operating Expenses, Other Income, net and Provision for Income Taxes
Current report — wording carried from elsewhere
Costs related to exit and disposal. Our decision to exit and close certain operations in Germany resulted in a $0.2 million expense related to the write-down of fixed assets and $0.1 million in personnel and related cost benefits during the six months ended June 30, 2025. These items are the result of changes from the estimated amounts accrued in 2024 and the timing of employee separation payments. We had no costs related to exit and disposal activities during the six months ended June 30, 2024.
Current report — wording carried from elsewhere
Other loss, net. We recognized other income, net of $3.2 million for the six months ended June 30, 2025, an increase of $0.9 million compared to other income, net of $2.3 million for the six months ended June 30, 2024. Other income, net for the six months ended June 30, 2025 primarily consisted of $2.3 million in interest income on investments, $0.5 million of foreign currency gains and $0.4 million of other income. Other income, net for the six months ended June 30, 2024 primarily consisted of $2.6 million in interest income on investments and other income, partially offset by a $0.3 million of foreign currency losses.